Resverlogix Corp. (RVXCF)

[noretreat]

The later the better as far as the futility analysis....because that means less than expected observation of MACE, all other things being equal. I recently got some of the latest info on enrollment, and if I can find decent numbers for EXPECTED MACE among the enrolled population, I should be able to extrapolate how the trial is going. Have to go back to the Phase 2 data.

PS I am on AGORACOM